Company Filing History:
Years Active: 2020
Title: Doyoung Chang: Innovator in Biopsy Plan Optimization
Introduction
Doyoung Chang is a notable inventor based in Rosedale, MD (US). He has made significant contributions to the field of medical technology, particularly in the optimization of biopsy plans. His innovative approach aims to enhance tumor detection probabilities, which is crucial for effective cancer diagnosis and treatment.
Latest Patents
Doyoung Chang holds a patent for a method titled "Geometric biopsy plan optimization." This invention focuses on calculating the tumor detection probability of a biopsy plan and generating a 3D biopsy plan that maximizes this probability. The method involves modeling a capsule-shaped volume to represent the area that a biopsy core may sample. An optimization technique is employed to create a 3D biopsy plan that maximizes the likelihood of tumor detection based on predefined biopsy core numbers and lengths. Additionally, the invention calculates the risk of detecting insignificant tumors and the probability of false negative results. It also provides a method to determine the number and length of biopsy cores required for individual patients, balancing the probabilities of detecting significant versus insignificant tumors based on prostate size and shape.
Career Highlights
Doyoung Chang is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations in medical technology. His work is instrumental in improving biopsy techniques, which can lead to better patient outcomes.
Collaborations
Doyoung has collaborated with esteemed colleagues such as Dan Stoianovici and Misop Han. Their combined expertise contributes to the development of cutting-edge solutions in the medical field.
Conclusion
Doyoung Chang's contributions to biopsy plan optimization represent a significant advancement in medical technology. His innovative methods enhance the accuracy of tumor detection, ultimately benefiting patient care and treatment strategies.